SynthesisJournal of clinical epidemiology2022

Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results.

Ariel Izcovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.